|
|
The lawyers at Stone & Magnanini are recognized as premier lawyers representing relators/whistleblowers in high-stakes complex False Claims Act matters.
| Recent significant False Claims Act settlements include: |
 |
| Bristol-Myers Squibb: |
| $425 million (Abilify, Serzone, oncology drugs -- off-label marketing & kickbacks) |
|
| Cephalon: |
| $350 million (Actiq, Gabitril, Provigil – off-label marketing & kickbacks) |
|
| Medco: |
| $165 million (switching & destroying prescriptions, other related illegal conduct) |
We currently represent a number of whistleblowers in significant False Claims Act
cases that remain under seal.
| Our current unsealed FCA cases include: |
|
| Forest Labs (government has intervened) |
 |
Off-label marketing of antidepressants Celexa and Lexapro to children and teens,
despite side effects including causing suicidal thoughts |
|
Kickbacks to doctors to prescribe the drugs |
|
|
